Ok‐Nam Bae
한양대학교 약학과 · 의학
Ok-Nam Bae 교수의 연구실은 뇌혈관 질환, 특히 뇌졸중과 당뇨병 관련 뇌혈관 합병증의 발달 기전을 규명하고자 합니다. 주로 카르노신의 신경보호 작용, 산화 스트레스 및 미토콘드리아 기능 이상이 뇌내피세포 기능 장애에 미치는 영향을 중심으로 연구를 진행하고 있으며, 특히 메틸글리옥살과 TSP-2가 관련된 분자 기전에 초점을 맞추고 있습니다. 또한 피부의 병리적 변화를 평가할 수 있는 생물학적 마커로서 VEGF의 임상적 잠재성에 대해서도 탐색하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
In both permanent and transient ischemic models, carnosine treatment exhibited significant cerebroprotection against histological and functional damage, with wide therapeutic and clinically relevant time windows. Carnosine was well tolerated and exhibited no toxicity. Mechanistic data show that it influences multiple deleterious processes. Taken together, our data suggest that this endogenous pleiotropic dipeptide is a strong candidate for further development as a stroke treatment.
The upregulation of TSP-2 mediated by increased oxidative stress contributes to angiogenesis dysfunction in diabetic BMACs.
Methylglyoxal (MG) is a dicarbonyl compound, the level of which is increased in the blood of diabetes patients. MG is reported to be involved in the development of cerebrovascular complications in diabetes, but the exact mechanisms need to be elucidated. Here, we investigated the possible roles of oxidative stress and mitophagy in MG-induced functional damage in brain endothelial cells (ECs). Treatment of MG significantly altered metabolic stress as observed by the oxygen-consumption rate and ba
Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal